BIO-TECHNE Corp (TECH)

SEC fundamentals · as filed in 10-K FY2026, period ended Jun 30, 2026 · updated Oct 20, 2026

Verified against EDGAR
Total Assets
$2.59B
Stockholders' Equity
$2.11B
Cash & Equivalents
$264.7M
Long-Term Debt
$200.0M

as filed in 10-K FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-K for the period ended Jun 30, 2026, BIO-TECHNE Corp reported revenue of $1.22B, net income of $181.8M, and total assets of $2.59B. Every figure below is taken directly from BIO-TECHNE Corp's SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2017–FY2026 · as reported

$1.22B$646.5M$73.4M
FY2017FY2020FY2023FY2026
Revenue$1.22BNet income$181.8M
FY2017 revenue
$563.0M
FY2026 revenue
$1.22B

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2026$1.22B$181.8M
FY2025$1.22B$73.4M
FY2024$1.16B$168.1M
FY2023$1.14B$285.3M
FY2022$1.11B$272.1M
FY2021$931.0M$140.4M
FY2020$738.7M$229.3M
FY2019$714.0M$96.1M
FY2018$643.0M$126.2M
FY2017$563.0M$76.1M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
10-K/AOct 28, 2026on EDGAR ↗
8-KSep 23, 2026on EDGAR ↗
8-KSep 14, 2026on EDGAR ↗
10-KAug 24, 2026on EDGAR ↗
8-KAug 12, 2026on EDGAR ↗
8-KJun 26, 2026on EDGAR ↗
8-KJun 25, 2026on EDGAR ↗
10-QMay 6, 2026on EDGAR ↗
8-KMay 6, 2026on EDGAR ↗
8-KFeb 11, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-K

Total Assets$2.59Bsource ↗
Stockholders’ Equity$2.11Bsource ↗
Cash & Equivalents$264.7Msource ↗
Long-Term Debt$200.0Msource ↗

Income Statement

10-K (annual) · period ended Jun 30, 2026

Revenue$1.22Bsource ↗
Net Income$181.8Msource ↗
Operating Income$251.9Msource ↗
Gross Profit$799.1Msource ↗
Cost of Revenue$416.0Msource ↗
R&D Expense$94.8Msource ↗

Per Share & Cash Flow

10-K (annual) · period ended Jun 30, 2026

EPS (diluted)$1.16source ↗
EPS (basic)$1.17source ↗
Shares Outstanding156.8Msource ↗
Cash from Operations$292.1Msource ↗
Cash from Financing-$169.1Msource ↗
Cash from Investing-$18.2Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
1
Net shares
-6.6K

Restatement history

Point-in-time

1 of 574 annual fact-keys were materially restated between filings: what BIO-TECHNE Corp first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches TECH’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TECH

MCP tool: get_sec_fundamentals ticker=TECH

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TECH/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=TECH as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/TECH/history

MCP tool: get_fundamentals_history ticker=TECH

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/TECH

MCP tool: get_financial_health ticker=TECH

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.